Company In-licenses State-of-the-art CE-Marked Cobalt-Chromium Coronary Stent Forms Alliance to Jointly Develop Drug Eluting Balloon Products RALEIGH, N.C., Jan.

RALEIGH, N.C., Dec. 8 /PRNewswire/ -- Micell Technologies announced today that it has appointed David Dresner to serve as the Company's Chief Financial Officer on an interim basis effective December 16, 2006. Mr.

RALEIGH, N.C., Aug. 31 /PRNewswire/ -- Micell Technologies has engaged Foster-Miller, Inc. for further development work and automation of its manufacturing process for creating drug-eluting coatings for medical devices.

RALEIGH, N.C., Aug. 9 /PRNewswire/ -- Micell Technologies announced an expansion of its license agreement for using supercritical fluids for creating medical device surface modifications with Pacific Northwest National Laboratory, a U.S. Department of Energy laboratory, managed by Battelle.

RALEIGH, N.C., July 17 /PRNewswire/ -- Micell Technologies announces the launch of its new website, providing information on the biomedical applications of the Company's technology.